Capital Grand Est
Overview
Capital Grand Est is an independent private equity firm that supports companies in the Grand Est region of France (Alsace, Champagne-Ardenne, and Lorraine). It provides equity and quasi-equity financing to support companies' development and buyout projects, from creation through growth. The firm was created in 2017 from the merger of the Institut Lorrain de Participation and Capital Investissement en Alsace (CIIA).
Portfolio Companies
17
Website
capitalgrandest.euInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| EVerZom | Oct 2025 | Series A | Lead |
| BrainTale | Jun 2023 | Series A | Lead |
| Next-Microbiome | Jun 2023 | Series A | Co-investor |
| Dianosic | Nov 2025 | Series A | Co-investor |
| Keey Aerogel | Jan 2025 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Capital Grand Est based?
Capital Grand Est is headquartered in France.
When was Capital Grand Est founded?
Founding year information for Capital Grand Est is not publicly available.
How many portfolio companies does Capital Grand Est have?
Capital Grand Est has 17 portfolio companies in Caplight's dataset.
What are some companies in Capital Grand Est's portfolio?
Portfolio companies visible on Caplight include EVerZom, BrainTale, Next-Microbiome, Dianosic, Keey Aerogel.
What was Capital Grand Est's most recent investment shown here?
Capital Grand Est's most recent investment in this portfolio sample was in Dianosic in 2025.
What sectors does Capital Grand Est focus on?
Capital Grand Est focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Mobility, Transportation & Logistics, Energy & Sustainability, Healthcare & Life Sciences, Enterprise Software, Consumer & Commerce, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Capital Grand Est focus on?
Capital Grand Est typically invests at the Early stage.
What is Capital Grand Est's AUM?
Capital Grand Est's assets under management are estimated between $237.6M and $243.0M.